There are 8 resources available
Welcome and Learning Objectives Introduction
Presenter: Ravindran Kanesvaran, SG, Solange Peters, CH
Session: Welcome and Introduction
Resources:
Slides
Mechanisms of Action and Resistance: ADC Internalization and Cleavage and Mechanisms of Resistance
Presenter: Aaron R. Hansen, AU
Session: Session 1 – ADC Development and Pharmacodynamics
Resources:
Slides
Webcast
Toxicity: Prediction, Identification and Treatment
Presenter: Tira J. Y. Tan, SG
Session: Session 1 – ADC Development and Pharmacodynamics
Resources:
Slides
Webcast
ADC Development: What are the Considerations in Early Phase Trials?
Presenter: David Planchard, FR
Session: Session 1 – ADC Development and Pharmacodynamics
Resources:
Slides
Webcast
Considerations from Pathology: Biomarker Selection, On-Target Off-Tumour Expression of Target Toxicities
Presenter: Nye-Thane Ngo, SG
Session: Session 2 – Target Assessment and Rationale for Combinations
Resources:
Slides
Webcast
Developments in ADC Constructs Including: Bispecific ADCs
Presenter: Egbert F. Smit, NL
Session: Session 3 – Next Generation ADCs
Resources:
Slides
Webcast
Additional Innovative Strategies: Cytokine Conjugates, Peptide-Based Conjugates
Presenter: Darren M. C. Poon, HK SAR, CN
Session: Session 3 – Next Generation ADCs
Resources:
Slides
Webcast
How to Develop Rationale Combinations and Sequencing
Presenter: Kelvin C. K. Yan, HK SAR, CN
Session: Session 3 – Next Generation ADCs
Resources:
Slides
Webcast